Consequently, these data suggest that additional pathogenic mechanisms could be implicated in MAS occurrence and together with the preclinical data, provided the rationale for IFN-γ inhibition in this field [31,34,35,36,38,39,40,41]. Here, IFNG is linked to macrophage activation syndrome.